Testosterone concentration and insulin sensitivity in young men with type 1 and type 2 diabetes
- PMID: 25611822
- PMCID: PMC4510044
- DOI: 10.1111/pedi.12255
Testosterone concentration and insulin sensitivity in young men with type 1 and type 2 diabetes
Abstract
Objective: Reduced testosterone, a recognized comorbidity of reduced insulin sensitivity (IS) and type 2 diabetes (T2D), has also been reported in adult males with type 1 diabetes (T1D). However, there are limited data on how early reduced testosterone occurs, and whether it is related to the reduced IS in T1D. Leptin, a modulator of the HPG-axis, may also influence testosterone in T1D. We hypothesized that IS and leptin would be associated with total testosterone (TT), and free androgen index (FAI) in adolescent males with T1D.
Methods: T1D (n = 35), T2D (n = 13), lean (n = 13) and obese (n = 9) adolescent males had IS measured by hyperinsulinemic-euglycemic clamps (glucose infusion rate [GIR]), in addition to leptin, sex hormone binding globulin (SHBG), TT, and FAI. The cohort was stratified into those with T1D (n = 35) and those without (n = 35).
Results: TT and SHBG were lower in T2D boys vs. lean controls, and GIR and leptin correlated with FAI and TT in non-T1D participants. However, despite being insulin resistant, adolescent males with T1D had normal TT and FAI, unrelated to GIR. In T1D, leptin was inversely associated with TT (p = 0.005) and FAI (p = 0.01), independent of puberty, hemoglobin A1c (HbA1c), diabetes duration, body mass index (BMI) z-score and GIR.
Conclusion: Leptin accounted for a significant proportion of the variability of testosterone in T1D. However, despite reduced IS, there was no association between IS and testosterone in T1D adolescents. These observations suggest that the mechanisms affecting testosterone may differ between adolescent males with and without T1D.
Keywords: insulin sensitivity; leptin; puberty; testosterone; type 1 diabetes.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Conflict of interest statement
Figures




References
-
- Dhindsa S, Prabhakar S, Sethi M, Bandyopadhyay A, Chaudhuri A, Dandona P. Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes. The Journal of clinical endocrinology and metabolism. 2004;89(11):5462–8. Epub 2004/11/09. - PubMed
-
- Kapoor D, Aldred H, Clark S, Channer KS, Jones TH. Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity. Diabetes Care. 2007;30(4):911–7. Epub 2007/03/30. - PubMed
-
- Moriarty-Kelsey M, Harwood JE, Travers SH, Zeitler PS, Nadeau KJ. Testosterone, obesity and insulin resistance in young males: evidence for an association between gonadal dysfunction and insulin resistance during puberty. Journal of pediatric endocrinology & metabolism : JPEM. 2010;23(12):1281–7. Epub 2011/07/01. - PMC - PubMed
-
- van Dam EW, Dekker JM, Lentjes EG, Romijn FP, Smulders YM, Post WJ, et al. Steroids in adult men with type 1 diabetes: a tendency to hypogonadism. Diabetes Care. 2003;26(6):1812–8. Epub 2003/05/27. - PubMed
-
- Rohrer T, Stierkorb E, Heger S, Karges B, Raile K, Schwab KO, et al. Delayed pubertal onset and development in German children and adolescents with type 1 diabetes: cross-sectional analysis of recent data from the DPV diabetes documentation and quality management system. European journal of endocrinology / European Federation of Endocrine Societies. 2007;157(5):647–53. Epub 2007/11/07. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous